Stocks and securities in focus
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Tonix Pharmaceuticals Holding Corp. | - | - | - | - | - | - | - |
Insmed Inc. | - | -3.521% | 0.735% | 242.500% | 139.510% | 195.259% | 358.071% |
iBio Inc. | -28.520% | - | - | - | - | - | - |
Inotiv Inc. | -12.320% | -11.888% | -26.744% | -61.818% | -61.585% | - | - |
Alnylam Pharmace. | -9.600% | -2.422% | 9.944% | 31.617% | 34.294% | 37.717% | 223.754% |
Arca Biopharma | -7.020% | -40.642% | -22.378% | 17.772% | 42.765% | -13.953% | -50.168% |
Celsion Corp. | -5.830% | -11.009% | -66.781% | -14.159% | 63.025% | -92.347% | -95.955% |
Fate Therapeutics Inc. | -5.690% | -5.413% | -32.316% | 32.742% | -9.589% | -94.716% | -78.362% |
Emergent Biosolutions Inc. | -5.650% | -11.461% | -31.204% | 81.337% | 238.420% | -86.063% | -81.079% |
Acorda Therapeutics Cdt | -2.970% | - | - | - | - | - | - |
Bayer AG ADR | -2.840% | 0.735% | 3.788% | -44.758% | -20.349% | -40.435% | -59.226% |
Bluebird Bio Inc. | -2.610% | -17.462% | -50.693% | -85.168% | -59.198% | -96.637% | -99.459% |
Arrowhead Pharmaceuticals Inc. | -2.250% | -2.576% | -19.160% | -13.553% | -23.438% | -61.962% | -31.118% |
Actinium Pharmaceuticals Inc. | -2.130% | 0.725% | -71.928% | -67.768% | -60.066% | -64.257% | -70.521% |
Verastem Inc. | -1.800% | 0.893% | -8.130% | 140.298% | -70.066% | -91.696% | -83.637% |
Adaptimmune Therapeutics PLC ADR | -1.750% | 6.481% | -5.738% | 51.316% | 84.000% | -73.624% | -21.233% |
Compugen Ltd. | -1.700% | - | - | - | - | - | - |
Minerva Neurosciences Inc. | -1.570% | 5.932% | -14.384% | -66.171% | -57.155% | -80.045% | - |
Ocular Therapeutix Inc. | -1.110% | -1.965% | 5.832% | 126.689% | 90.276% | -14.610% | 126.144% |
Neurocrine Bioscience | -1.080% | -15.751% | -11.911% | 15.857% | -3.604% | 41.382% | 27.100% |
Riot Blockchain Inc. | -1.020% | -10.421% | -28.995% | -38.277% | -57.830% | -78.698% | 305.479% |
MacroGenics Inc. | -0.960% | 5.929% | -37.030% | -29.018% | -64.667% | -83.870% | -75.379% |
Novocure Ltd | -0.620% | 10.773% | -17.407% | -11.155% | 24.974% | -84.358% | -78.485% |
Agios Pharmaceuticals Inc. | -0.490% | 0.971% | -4.147% | 67.742% | 101.942% | 11.528% | 20.458% |
UnitedHealth Group Inc. | -0.390% | 2.182% | 0.094% | 18.491% | 12.025% | 50.557% | 150.964% |
Cardiff Oncology Inc. | -0.240% | -0.477% | -2.113% | 26.517% | 58.435% | -66.905% | 21.887% |
Sanofi S.A. | -0.220% | 1.354% | 6.430% | 2.518% | 13.426% | 15.603% | 30.262% |
Acadia Pharmaceuticals | -0.210% | -0.703% | -17.973% | -43.500% | -50.264% | -1.807% | -43.658% |
G1 Therapeutics | 0.080% | 0.235% | 73.954% | 314.563% | 132.909% | -48.554% | - |
Thermo Fisher Scientific Inc. | 0.400% | 2.752% | -2.215% | 8.652% | 15.415% | 17.512% | 113.183% |